General Information of Drug (ID:
DR2349) |
Drug Name |
W-108598
|
Synonyms |
Eustigmin bromide; Neostigmine bromide; Kirkstigmine bromide; Leostigmine bromide; Neoserine bromide; Neostigmine methyl bromide; Neostigmini bromidum; Philostigmin bromide; Proserine bromide; Prostigmin; Prostigmin bromide; Prostigmine bromide; Stigmanol bromide; Stigmosan bromide; Synstigmin bromide; Synstigmini bromidum; Synthostigmine bromide; Syntostigmin bromide; Syntostigmine bromide; Vagostigmin; Vagostigmine bromide; neo-Proserin; neostigmine bromide; 114-80-7; 3-((Dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium bromide
|
Indication |
Myasthenia gravis
[ICD11: 8C60]
|
Phase 2
|
[1]
|
Structure |
|
|
3D MOL is unavailable
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
303.2 |
Topological Polar Surface Area |
29.5 |
Heavy Atom Count |
17 |
Rotatable Bond Count |
3 |
Hydrogen Bond Donor Count |
0 |
Hydrogen Bond Acceptor Count |
3 |
Cross-matching ID |
- PubChem CID
- 8246
- ChEBI ID
-
- CAS Number
-
- Formula
- C12H19BrN2O2
- Canonical SMILES
- CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-]
- InChI
- 1S/C12H19N2O2.BrH/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5;/h6-9H,1-5H3;1H/q+1;/p-1
- InChIKey
- LULNWZDBKTWDGK-UHFFFAOYSA-M
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.